Outpatient worsening of heart failure and mortality in transthyretin amyloid cardiomyopathy. Zeldin L, Eichler JBS, Teruya SL, Weinsaft AY, et al. Eur J Heart Fail 2024 Dec 5. doi: 10.1002/ejhf.3540.

Read + Share

Amedeo Smart

Independent Medical Education

Zeldin L, Eichler JBS, Teruya SL, Weinsaft AY, et al. Outpatient worsening of heart failure and mortality in transthyretin amyloid cardiomyopathy. Eur J Heart Fail 2024 Dec 5. doi: 10.1002/ejhf.3540.
PMID: 39638976